Development of a Fish Cell Biosensor System for Genotoxicity Detection Based on DNA Damage-Induced Trans-Activation

Deyu Geng1, Zhixia Zhang2, Huarong Guo3

  • 1Department of Marine Biology, Ocean University of China, Qingdao 266003, China. doarey@126.com.

Biosensors
|January 15, 2015
PubMed

Insights

A novel fish cell biosensor, p21FGLuc, detects genotoxicity in new drugs. This system accurately identifies harmful compounds by monitoring the p21 gene, offering a sensitive and specific tool for drug safety assessment.

Area of Science:

  • Biotechnology
  • Toxicology
  • Cellular Biology

Background:

  • The p21 gene is a crucial p53 target, activated by cellular DNA damage.
  • High-throughput genotoxicity testing is essential for new drug development.
  • Existing in vitro assays have limitations in detecting certain genotoxic agents.

Purpose of the Study:

  • To develop and validate a fish cell biosensor for high-throughput genotoxicity detection.
  • To assess the sensitivity and specificity of the biosensor for various genotoxic and non-genotoxic agents.
  • To evaluate the biosensor's utility in detecting the genotoxicity of Di(2-ethylhexyl) phthalate (DEHP).

Main Methods:

  • Development of a stable fish cell line (p21FGLuc) by integrating two reporter plasmids (pGL3-p21-luc and pRL-CMV-luc) into flounder gill (FG) cells.
  • Validation of the biosensor's p53 signaling pathway and response to known genotoxic agents (bleomycin, mitomycin C, cyclophosphamide with/without metabolic activation).
  • Testing the biosensor's response to non-genotoxic agents (ethanol, D-mannitol) and DEHP.

Main Results:

  • The p21FGLuc biosensor demonstrated a wild-type p53 signaling pathway.
  • The system showed high sensitivity and specificity, correctly identifying genotoxic agents and distinguishing them from non-genotoxic ones.
  • The biosensor provided a strong indication of DEHP genotoxicity, overcoming limitations of other assays.

Conclusions:

  • The p21FGLuc fish cell biosensor is a validated, sensitive, and specific tool for high-throughput genotoxicity testing.
  • This system offers a reliable method for assessing the safety of new drugs and identifying genotoxic compounds like DEHP.
  • A potential limitation includes false positives from agents that activate the p21 gene independently of p53.